Brii Biosciences Limited

SEHK:2137 Stock Report

Market Cap: HK$775.0m

Brii Biosciences Balance Sheet Health

Financial Health criteria checks 6/6

Brii Biosciences has a total shareholder equity of CN¥2.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.9B and CN¥86.3M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥2.39b
EquityCN¥2.81b
Total liabilitiesCN¥86.31m
Total assetsCN¥2.90b

Recent financial health updates

Recent updates

Brii Biosciences (HKG:2137) Is In A Good Position To Deliver On Growth Plans

Nov 19
Brii Biosciences (HKG:2137) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not Too Worried About Brii Biosciences' (HKG:2137) Cash Burn Situation

Jul 26
Here's Why We're Not Too Worried About Brii Biosciences' (HKG:2137) Cash Burn Situation

Companies Like Brii Biosciences (HKG:2137) Are In A Position To Invest In Growth

Jan 12
Companies Like Brii Biosciences (HKG:2137) Are In A Position To Invest In Growth

We're Hopeful That Brii Biosciences (HKG:2137) Will Use Its Cash Wisely

Sep 20
We're Hopeful That Brii Biosciences (HKG:2137) Will Use Its Cash Wisely

We're Not Worried About Brii Biosciences' (HKG:2137) Cash Burn

Mar 24
We're Not Worried About Brii Biosciences' (HKG:2137) Cash Burn

Financial Position Analysis

Short Term Liabilities: 2137's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥67.7M).

Long Term Liabilities: 2137's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥18.6M).


Debt to Equity History and Analysis

Debt Level: 2137 is debt free.

Reducing Debt: 2137 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 2137 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 2137 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 7.6% each year


Discover healthy companies